Treatment Modalities and Risks of Complication for Patients With Localized Renal Cell Carcinoma Aged 75 and Older

Chalairat Suk‐ouichai,Hiten D. Patel,Kent T. Sato,Shilajit D. Kundu,Ashley E. Ross,Kent T. Perry
DOI: https://doi.org/10.1002/jso.27962
2024-10-31
Journal of Surgical Oncology
Abstract:Background and Objectives Partial (PN)/radical (RN) nephrectomy is the standard treatment for localized renal‐cell carcinoma (RCC). The potential risks of these procedures are concerns for the elderly. We evaluated perioperative outcomes/survival for patients aged ≥ 75 years with localized RCC who underwent PN, RN, or thermal ablation (TA). Methods Localized RCC patients undergoing PN/RN/TA (2000–2023) were retrospectively reviewed. Logistic‐regression assessed factors associated with major complications. Kaplan‐Meier estimated survival. Results A total of 278 patients (≥ 75 years) with RCC who received intervention (107RN, 101PN, and 70TA) were identified. Median age was 78 years. PN patients were younger than other cohorts (77 vs. 79, p = 0.006). Patients with cancer comorbidities underwent TA than PN/RN (93% vs. 88%/76%, respectively). Median tumor size was 4.0, 3.0, and 2.6 cm in RN, PN, and TA cohorts, respectively. RN patients had more complex masses compared to other cohorts (9 vs. 7, p
oncology,surgery
What problem does this paper attempt to address?